---
title: 5-MeO-DiPT
description: 
published: true
date: 2026-01-30T09:23:45.197Z
tags: 
editor: markdown
dateCreated: 2026-01-30T05:54:32.842Z
---

[â—€è¿”å›](/è¯ç‰©/home.md)

<mark> è¿˜ä¸é”™å“ˆ</mark>


# 5-MeO-DiPT

| 5-MeO-DiPT | |
| --- | --- |
| [![5-MeO-DiPT.svg](/æ–‡ä»¶/5-MeO-DiPT.svg)](/æ–‡ä»¶/5-MeO-DiPT.svg) | |
| **åŒ–å­¦å‘½å** | |
| ä¿—å | *5-MeO-DiPT, Foxy Methoxy, Foxy* |
| å–ä»£åç§° | *5-ç”²æ°§åŸº-äºŒå¼‚ä¸™åŸºè‰²èƒº* |
| ç³»ç»Ÿå‘½åæ³•åç§° | *[2-(5-Methoxy-1H-indol-3-yl)ethyl]bis(propan-2-yl)amine* |
| **åˆ†ç±»æˆå‘˜** | |
| ç²¾ç¥æ´»æ€§åˆ†ç±» | *[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)* |
| åŒ–å­¦åˆ†ç±» | *[è‰²èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)* |

| [ç»™è¯é€”å¾„](/æ–‡æ¡£/ç»™è¯é€”å¾„.md) | [å£æœ](/æ–‡æ¡£/ç»™è¯é€”å¾„.md#å£æœ) |
| --- | --- |
| **è­¦å‘Šï¼š** ç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€æ–°é™ˆä»£è°¢å’Œä¸ªäººæ•æ„Ÿåº¦çš„å·®å¼‚ï¼Œè¯·å§‹ç»ˆä»ä½å‰‚é‡å¼€å§‹ã€‚[å‚è§è´Ÿè´£ä»»çš„ç”¨è¯éƒ¨åˆ†](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚ | |
| **[ç»™è¯å‰‚é‡](/æ–‡æ¡£/ç»™è¯å‰‚é‡.md)** | |
| [é˜ˆå€¼](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#é˜ˆå€¼) | 3 mg |
| [è½»å¾®](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#è½»å¾®) | 3 - 10 mg |
| [ä¸­ç­‰](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸­ç­‰) | 10 - 15 mg |
| [å¼ºçƒˆ](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#å¼ºçƒˆ) | 15 - 20 mg |
| [ä¸¥é‡](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸¥é‡) | 20 mg + |
| **[è¯æ•ˆæ—¶é•¿](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md)** | |
| [æ€»æ—¶é•¿](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#æ€»æ—¶é•¿) | 4 - 8 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆå‘ä½œ) | 20 - 40 åˆ†é’Ÿ |
| [è¯æ•ˆæ®‹ä½™](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆæ®‹ä½™) | 2 - 6 å°æ—¶ |

<br>

> **[å…è´£å£°æ˜](/å…³äºæœ¬ç«™/è§‚å‰æé†’.md)ï¼š** æœ¬ç«™çš„[ç»™è¯å‰‚é‡](/æ–‡æ¡£/ç»™è¯å‰‚é‡.md)ä¿¡æ¯æ”¶é›†è‡ªç”¨æˆ·å’Œ[èµ„æº](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)ï¼Œä»…ç”¨äºæ•™è‚²ç›®çš„ã€‚è¿™å¹¶éæ¨èï¼Œä¸”åº”é€šè¿‡å…¶ä»–æ¥æºæ ¸å®ä»¥ç¡®ä¿å‡†ç¡®æ€§ã€‚

**5-ç”²æ°§åŸº-N,N-äºŒå¼‚ä¸™åŸºè‰²èƒº**ï¼ˆä¹Ÿç§°ä¸º **5-MeO-DiPT**ã€**Foxy** å’Œ **Foxy Methoxy**ï¼‰æ˜¯ä¸€ç§[è‰²èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)ç±»åˆ«çš„æ–°å‹[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)ç‰©è´¨ï¼Œåœ¨[ç»™è¯](/æ–‡æ¡£/ç»™è¯é€”å¾„.md)æ—¶ä¼šäº§ç”Ÿ[è¿·å¹»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)æ•ˆåº”ã€‚å…¶ç»“æ„ä¸ [DiPT](./DiPT.md) å’Œ [5-MeO-MiPT](./5-MeO-MiPT.md) ç›¸å…³ã€‚

5-MeO-DiPT çš„é¦–æ¬¡äººä½“è¯•éªŒç”±äºšå†å±±å¤§Â·èˆ’å°”é‡‘äº 1975 å¹´è¿›è¡Œ[\[1\]](#cite_note-1)ï¼Œä»–äº 1981 å¹´åˆè‘—å¹¶å‘è¡¨äº†ä¸€ç¯‡è¯¦ç»†ä»‹ç»å…¶åˆæˆå’Œäººä½“ç²¾ç¥è¯ç†å­¦çš„è®ºæ–‡[\[2\]](#cite_note-2)ã€‚èˆ’å°”é‡‘ 1997 å¹´å‡ºç‰ˆçš„ä¹¦ç±ã€Š*TiHKAL*ã€‹ï¼ˆâ€œæˆ‘æ‰€çŸ¥å’Œå–œçˆ±çš„è‰²èƒºâ€ï¼‰ä¸­åŒ…å«äº†å…¶åˆæˆæ‘˜è¦å’Œäººä½“ä½¿ç”¨æŠ¥å‘Š[\[3\]](#cite_note-Shulgin1997-3)ã€‚

è½¶äº‹æŠ¥å‘Šå°†è¯¥åŒ–åˆç‰©çš„æ•ˆåº”æè¿°ä¸ºé«˜åº¦[åˆºæ¿€](/è¯æ•ˆ/åˆºæ¿€.md)å’Œè½»åº¦[å…±æƒ…å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md)ï¼Œç¼ºä¹å…¸å‹çš„è¿·å¹»è§†è§‰æ‰­æ›²ã€‚è®¸å¤šç”¨æˆ·æŠ¥å‘Šæœ‰å¼ºçƒˆçš„èº«ä½“å’Œè§¦è§‰æ•ˆåº”ï¼Œæœ‰åŠ©äº[å¢å¼ºæ€§æ¬²](/è¯æ•ˆ/æ€§æ¬²å¢å¼º.md)å’Œæ€§å¿«æ„Ÿã€‚è®¸å¤šç”¨æˆ·æŒ‡å‡ºï¼Œè¾ƒé«˜å‰‚é‡ä¼šä¼´éšä»¤äººä¸é€‚çš„èº«ä½“è´Ÿè·ã€‚ä¸€äº›ç”¨æˆ·è¿˜æŠ¥å‘Šäº†å£°éŸ³æ‰­æ›²ï¼Œè¿™ä¸€ç‚¹åœ¨ç›¸å…³åŒ–åˆç‰© [DiPT](./DiPT.md) ä¸­ä¹Ÿæœ‰è®°å½•ã€‚

å…³äº 5-MeO-DiPT çš„è¯ç†ç‰¹æ€§ã€ä»£è°¢å’Œæ¯’æ€§çŸ¥ä¹‹ç”šå°‘ã€‚å®ƒç›¸å¯¹å†·é—¨ï¼Œäººç±»ä½¿ç”¨å†å²æœ‰é™ã€‚å®ƒæ›¾ä½œä¸º[ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)åœ¨ç½‘ä¸Šå‡ºå”®ã€‚å¦‚æœä½¿ç”¨è¯¥ç‰©è´¨ï¼Œå¼ºçƒˆå»ºè®®é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚

## ç›®å½•

* [1 åŒ–å­¦](#åŒ–å­¦)
* [2 è¯ç†å­¦](#è¯ç†å­¦)
* [3 ä¸»è§‚æ•ˆåº”](#ä¸»è§‚æ•ˆåº”)
    * [3.1 èº¯ä½“æ•ˆåº”](#èº¯ä½“æ•ˆåº”)
    * [3.2 è§†è§‰æ•ˆåº”](#è§†è§‰æ•ˆåº”)
        * [3.2.1 å¢å¼º](#å¢å¼º)
        * [3.2.2 æ‰­æ›²](#æ‰­æ›²)
        * [3.2.3 å‡ ä½•](#å‡ ä½•)
        * [3.2.4 å¹»è§‰çŠ¶æ€](#å¹»è§‰çŠ¶æ€)
    * [3.3 è®¤çŸ¥æ•ˆåº”](#è®¤çŸ¥æ•ˆåº”)
    * [3.4 å¬è§‰æ•ˆåº”](#å¬è§‰æ•ˆåº”)
    * [3.5 ä½“éªŒæŠ¥å‘Š](#ä½“éªŒæŠ¥å‘Š)
* [4 æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›](#æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›)
    * [4.1 è¿‡é‡](#è¿‡é‡)
    * [4.2 è€å—æ€§å’Œæˆç˜¾æ½œåŠ›](#è€å—æ€§å’Œæˆç˜¾æ½œåŠ›)
    * [4.3 å±é™©çš„ç›¸äº’ä½œç”¨](#å±é™©çš„ç›¸äº’ä½œç”¨)
* [5 æ³•å¾‹åœ°ä½](#æ³•å¾‹åœ°ä½)
* [6 å¦è§](#å¦è§)
* [7 å¤–éƒ¨é“¾æ¥](#å¤–éƒ¨é“¾æ¥)
    * [7.1 è®¨è®º](#è®¨è®º)
* [8 å‚è€ƒèµ„æ–™](#å‚è€ƒèµ„æ–™)

## åŒ–å­¦

5-MeO-DiPTï¼Œå³ 5-ç”²æ°§åŸº-N,N-äºŒå¼‚ä¸™åŸºè‰²èƒºï¼Œæ˜¯ä¸€ç§[è‰²èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)ç±»åˆ«çš„åˆæˆå²å“šç”Ÿç‰©ç¢±åˆ†å­ã€‚è‰²èƒºç±»ç‰©è´¨å…±äº«ä¸€ä¸ªæ ¸å¿ƒç»“æ„ï¼Œè¯¥ç»“æ„ç”±ä¸€ä¸ªåŒç¯å²å“šæ‚ç¯ç»„æˆï¼Œè¯¥æ‚ç¯åœ¨ R3 å¤„é€šè¿‡ä¹™åŸºä¾§é“¾è¿æ¥åˆ°ä¸€ä¸ªæ°¨åŸºä¸Šã€‚5-MeO-DiPT åœ¨å…¶å²å“šæ‚ç¯çš„ R5 å¤„è¢«ç”²æ°§åŸº (MeO) å®˜èƒ½å›¢ CH3Oâˆ’ å–ä»£ï¼›å®ƒè¿˜åœ¨å…¶è‰²èƒºä¸»é“¾çš„æœ«ç«¯èƒº RN ä¸Šç»“åˆäº†ä¸¤ä¸ªå¼‚ä¸™åŸºé“¾ (DiPT)ã€‚

5-MeO-DiPT æ˜¯ [5-MeO-MiPT](./5-MeO-MiPT.md) çš„ N-å–ä»£äºŒå¼‚ä¸™åŸºåŒç³»ç‰©ã€‚

## è¯ç†å­¦

æ›´å¤šä¿¡æ¯ï¼š[è¡€æ¸…ç´ èƒ½è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)

5-MeO-DiPT äº§ç”Ÿçš„æ‰€è°“è‡´å¹»å’Œè‡´ç¥æ•ˆåº”çš„æœºåˆ¶è¢«è®¤ä¸ºä¸»è¦æºäº 5-HT2A å—ä½“æ¿€åŠ¨ä½œç”¨ï¼Œå°½ç®¡å…¶ä»–ä½œç”¨æœºåˆ¶å¦‚å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶ (MAOI) ä¹Ÿå¯èƒ½å‚ä¸å…¶ä¸­ã€‚[\[4\]](#cite_note-pmid17223101-4) 5-MeO-DiPT æœ€å¼ºçš„å—ä½“ç»“åˆäº²å’ŒåŠ›æ˜¯åœ¨ 5-HT1A å—ä½“ä¸Šã€‚[\[5\]](#cite_note-5) ç„¶è€Œï¼Œè¿™äº›ç›¸äº’ä½œç”¨çš„ä½œç”¨ä»¥åŠå®ƒä»¬å¦‚ä½•å¯¼è‡´[è¿·å¹»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)ä½“éªŒä»ç„¶éš¾ä»¥æ‰æ‘¸ã€‚

5-MeO-DiPT åœ¨å¤§é¼ ä¸­å…·æœ‰ç¥ç»æ¯’æ€§ã€‚[\[6\]](#cite_note-Noworyta-Sokolowska2016-6)

## ä¸»è§‚æ•ˆåº”

| ![Metacogghjgjvghnition.png](/æ–‡ä»¶/Metacogghjgjvghnition.png) | **æœ¬ä¸»è§‚æ•ˆåº”ç« èŠ‚æ˜¯ä¸€ä¸ª[å°èŠ‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)**ã€‚<br>*å› æ­¤ï¼Œå®ƒä»åœ¨è¿›è¡Œä¸­ï¼Œå¯èƒ½åŒ…å«ä¸å®Œæ•´æˆ–é”™è¯¯çš„ä¿¡æ¯ã€‚*<br>*æ‚¨å¯ä»¥é€šè¿‡[æ‰©å±•æˆ–æ›´æ­£å®ƒ](https://psychonautwiki.org/w/index.php?title=5-MeO-DiPT&action=edit)æ¥æä¾›å¸®åŠ©ã€‚* |
| --- | --- |

***å…è´£å£°æ˜ï¼š** ä¸‹ä¸‹åˆ—å‡ºçš„æ•ˆåº”å¼•ç”¨äº†[***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](/è¯æ•ˆ/home.md) (**SEI**)ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ [PsychonautWiki](/å…³äºæœ¬ç«™/home.md) è´¡çŒ®è€…ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”ä»¥å¥åº·çš„æ€€ç–‘æ€åº¦çœ‹å¾…è¿™äº›å†…å®¹ã€‚*

*åŒæ ·å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆåº”ä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡è¾ƒé«˜å‰‚é‡æ›´å¯èƒ½è¯±å‘å…¨æ–¹ä½çš„æ•ˆåº”ã€‚åŒæ ·ï¼Œ**ä¸è‰¯ååº”**éšç€å‰‚é‡çš„å¢åŠ è€Œå˜å¾—è¶Šæ¥è¶Šå¯èƒ½ï¼Œå¯èƒ½åŒ…æ‹¬**æˆç˜¾ã€ä¸¥é‡ä¼¤å®³æˆ–æ­»äº¡*** â˜ ã€‚

### **èº¯ä½“æ•ˆåº”**

*   **[åˆºæ¿€](/è¯æ•ˆ/åˆºæ¿€.md)**
*   **[ä¸é€‚æ€§èº¯ä½“æ•ˆåº”](/è¯æ•ˆ/ä¸é€‚æ€§èº¯ä½“æ•ˆåº”.md)**
*   **[èº¯ä½“å‹åŠ›æ„Ÿ](/è¯æ•ˆ/èº¯ä½“å‹åŠ›æ„Ÿ.md)**
*   **[æ¶å¿ƒ](/è¯æ•ˆ/æ¶å¿ƒ.md)**
*   **[å¿ƒå¾‹å¼‚å¸¸](/è¯æ•ˆ/å¿ƒå¾‹å¼‚å¸¸.md)**\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **[å¿ƒç‡å¢å¿«](/è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)**\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **[è¡€å‹å‡é«˜](/è¯æ•ˆ/è¡€å‹å‡é«˜.md)**\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **[å¤´ç—›](/è¯æ•ˆ/å¤´ç—›.md)**\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **[èƒƒèƒ€](/è¯æ•ˆ/èƒƒèƒ€.md)** - åœ¨è¾ƒé«˜å‰‚é‡ä¸‹ï¼Œè¯¥åŒ–åˆç‰©å¯åœ¨æ˜“æ„Ÿäººç¾¤ä¸­å¼•èµ·ä¸¥é‡çš„èƒƒèƒ€ã€‚è¿™å¯ä»¥é€šè¿‡ä½¿ç”¨æŠ—é…¸å‰‚éƒ¨åˆ†æˆ–å®Œå…¨ç¼“è§£ã€‚
*   **[è¡€ç®¡æ”¶ç¼©](/è¯æ•ˆ/å¿ƒè¡€ç®¡æ•ˆåº”.md)**
*   **[è…¹æ³»](/è¯æ•ˆ/è…¹æ³».md)**
*   **[è„±æ°´](/è¯æ•ˆ/è„±æ°´.md)**
*   **[ç³å­”æ‰©å¤§](/è¯æ•ˆ/ç³å­”æ‰©å¤§.md)**

### **è§†è§‰æ•ˆåº”**

#### å¢å¼º
*   **[é¢œè‰²å¢å¼º](/è¯æ•ˆ/é¢œè‰²å¢å¼º.md)**
*   **[æ¨¡å¼è¯†åˆ«å¢å¼º](/è¯æ•ˆ/æ¨¡å¼è¯†åˆ«å¢å¼º.md)**
*   **[è§†è§‰é”åº¦å¢å¼º](/è¯æ•ˆ/è§†è§‰é”åº¦å¢å¼º.md)**

#### æ‰­æ›²
*   **[æ¼‚ç§»](/è¯æ•ˆ/æ¼‚ç§».md)** *([èåŒ–](/è¯æ•ˆ/æ¼‚ç§».md)ã€[å‘¼å¸](/è¯æ•ˆ/æ¼‚ç§».md)ã€[å˜å½¢](/è¯æ•ˆ/æ¼‚ç§».md) å’Œ [æµåŠ¨](/è¯æ•ˆ/æ¼‚ç§».md))*
*   **[é¢œè‰²åç§»](/è¯æ•ˆ/é¢œè‰²åç§».md)**
*   **[æ·±åº¦æ„ŸçŸ¥æ‰­æ›²](/è¯æ•ˆ/æ·±åº¦æ„ŸçŸ¥æ‰­æ›².md)**
*   **[é€è§†æ‰­æ›²](/è¯æ•ˆ/è§†è§‰æ‰­æ›².md)**
*   **å¯¹ç§°çº¹ç†é‡å¤**
*   **[æ®‹å½±](/è¯æ•ˆ/æ®‹å½±.md)**
*   **æ®‹åƒ**
*   **[äº®åº¦æ”¹å˜](/è¯æ•ˆ/äº®åº¦æ”¹å˜.md)**
*   **[è¡å°„](/è¯æ•ˆ/è¡å°„.md)**

#### [å‡ ä½•](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)

#### å¹»è§‰çŠ¶æ€
*   **[å˜å½¢](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)**
*   **[å†…éƒ¨å¹»è§‰](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)** (*[è‡ªä¸»å®ä½“](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)*; *[è®¾ç½®ã€é£æ™¯å’Œæ™¯è§‚](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)*; *[é€è§†å¹»è§‰](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)* å’Œ *[åœºæ™¯å’Œæƒ…èŠ‚](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)*)

### **è®¤çŸ¥æ•ˆåº”**

*   **[æ¦‚å¿µæ€ç»´](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[è®¤çŸ¥æ¬£å¿«](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[å¦„æƒ³](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æƒ…ç»ªå¢å¼º](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ²‰æµ¸æ„Ÿå¢å¼º](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[éŸ³ä¹é‰´èµèƒ½åŠ›å¢å¼º](/è¯æ•ˆ/å¬è§‰å¢å¼º.md)**
*   **[è®°å¿†æŠ‘åˆ¶](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
    *   **[è‡ªæˆ‘æ­»äº¡](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ–°å¥‡æ„Ÿå¢å¼º](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[ä¸ªäººåè§æŠ‘åˆ¶](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ€ç»´å¾ªç¯](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ—¶é—´æ‰­æ›²](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[ç»Ÿä¸€æ„Ÿå’Œç›¸äº’è”ç³»æ„Ÿ](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**

### **å¬è§‰æ•ˆåº”**

*   **[å¢å¼º](/è¯æ•ˆ/å¬è§‰å¢å¼º.md)**
*   **[æ‰­æ›²](/è¯æ•ˆ/å¬è§‰å¢å¼º.md)**
*   **[å¹»è§‰](/è¯æ•ˆ/å¬è§‰å¢å¼º.md)**

### ä½“éªŒæŠ¥å‘Š

ç›®å‰æˆ‘ä»¬çš„[ä½“éªŒç´¢å¼•](/æŠ¥å‘Š/psychounautwiki/home.md)ä¸­æ²¡æœ‰æè¿°è¯¥åŒ–åˆç‰©æ•ˆåº”çš„è½¶äº‹æŠ¥å‘Šã€‚æ›´å¤šçš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°ï¼š

*   [Erowid Experience Vaults: 5-MeO-DiPT](https://erowid.org/experiences/subs/exp_5MeODiPT.shtml)

## æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›

**æœ¬æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›éƒ¨åˆ†æ˜¯ä¸€ä¸ª[å°èŠ‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)ã€‚**å› æ­¤ï¼Œå®ƒå¯èƒ½åŒ…å«ä¸å®Œæ•´ç”šè‡³**æå…¶é”™è¯¯**çš„ä¿¡æ¯ï¼æ‚¨å¯ä»¥é€šè¿‡[æ‰©å±•æˆ–æ›´æ­£å®ƒ](https://psychonautwiki.org/w/index.php?title=5-MeO-DiPT&action=edit)æ¥æä¾›å¸®åŠ©ã€‚
*æ³¨æ„ï¼šå¦‚æœä½¿ç”¨æ­¤ç‰©è´¨ï¼Œè¯·åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶å¹¶ä½¿ç”¨**[ä¼¤å®³å‡å°‘æªæ–½](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)**ã€‚*

æ›´å¤šä¿¡æ¯ï¼š[ç ”ç©¶ç”¨åŒ–å­¦å“ Â§ æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ï¼Œä»¥åŠ [è´Ÿè´£ä»»çš„ç”¨è¯ Â§ è‡´å¹»å‰‚](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)

å¨±ä¹æ€§ä½¿ç”¨ 5-MeO-DiPT çš„é•¿æœŸå¥åº·å½±å“ä¼¼ä¹å°šæœªåœ¨ä»»ä½•ç§‘å­¦èƒŒæ™¯ä¸‹è¿›è¡Œç ”ç©¶ï¼Œç¡®åˆ‡çš„æ¯’æ€§å‰‚é‡å°šä¸æ¸…æ¥šã€‚è¿™æ˜¯å› ä¸º 5-MeO-DiPT æ˜¯ä¸€ç§äººç±»ä½¿ç”¨å†å²éå¸¸çŸ­çš„[ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ã€‚å…¶ç¥ç»æ¯’æ€§æ•ˆåº”å·²åœ¨å¤§é¼ ä¸­è¿›è¡Œäº†ç ”ç©¶ã€‚[\[6\]](#cite_note-Noworyta-Sokolowska2016-6)

è½¶äº‹æŠ¥å‘Šè¡¨æ˜ï¼Œå•ç‹¬ä»¥ä½è‡³ä¸­ç­‰å‰‚é‡å°è¯•æˆ–éå¸¸å°‘é‡åœ°ä½¿ç”¨å®ƒä¼¼ä¹æ²¡æœ‰è´Ÿé¢å¥åº·å½±å“ï¼ˆä½†æ²¡æœ‰ä»»ä½•äº‹æƒ…æ˜¯å¯ä»¥å®Œå…¨ä¿è¯çš„ï¼‰ã€‚åœ¨æ¶ˆè´¹å‰ï¼Œåº”å§‹ç»ˆè¿›è¡Œ[ç‹¬ç«‹ç ”ç©¶](https://www.google.com/)ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆæ˜¯å®‰å…¨çš„ã€‚

å¼ºçƒˆå»ºè®®åœ¨ä½¿ç”¨è¯¥ç‰©è´¨æ—¶é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚

### è¿‡é‡

è¿‡é‡æœç”¨åœ¨ä¸€äº›å¹´è½»äººä¸­å¼•èµ·äº†[æ¶å¿ƒ](/è¯æ•ˆ/æ¶å¿ƒ.md)ã€å‘•åã€æ¿€è¶Šã€[è¡€å‹é™ä½](/è¯æ•ˆ/è¡€å‹é™ä½.md)ã€[ç³å­”æ‰©å¤§](/è¯æ•ˆ/ç³å­”æ‰©å¤§.md)ã€[å¿ƒç‡å¢å¿«](/è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)å’Œå¹»è§‰ã€‚ä¸€åå¹´è½»ç”·å­å‘ç”Ÿäº†æ¨ªçº¹è‚Œæº¶è§£å’Œè‚¾è¡°ç«­ï¼Œå¦ä¸€åç”·å­åœ¨æ˜æ˜¾çš„ç›´è‚ ç»™è¯è¿‡é‡å 3-4 å°æ—¶æ­»äº¡ã€‚[\[7\]](#cite_note-7) ä¸€å 24 å²ç”·å­ä¹Ÿå› å°†è¯¥åŒ–åˆç‰©æ³¨å…¥ç»“è‚ è€Œæ­»äº¡ã€‚

### è€å—æ€§å’Œæˆç˜¾æ½œåŠ›

ä¸å…¶ä»–[è¡€æ¸…ç´ èƒ½è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)ä¸€æ ·ï¼Œ5-MeO-DiPT ä¸ä¼šå½¢æˆä¹ æƒ¯ã€‚

å¯¹ 5-MeO-DiPT æ•ˆåº”çš„è€å—æ€§åœ¨æ‘„å…¥åå‡ ä¹ç«‹å³å»ºç«‹ã€‚ä¹‹åï¼Œå¤§çº¦éœ€è¦ 3 å¤©æ—¶é—´è€å—æ€§æ‰ä¼šå‡åŠï¼Œ7 å¤©æ‰èƒ½æ¢å¤åˆ°åŸºçº¿ï¼ˆåœ¨æ²¡æœ‰è¿›ä¸€æ­¥æ¶ˆè´¹çš„æƒ…å†µä¸‹ï¼‰ã€‚5-MeO-DiPT ä¸æ‰€æœ‰[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)å­˜åœ¨äº¤å‰è€å—ï¼Œè¿™æ„å‘³ç€åœ¨æ¶ˆè´¹ 5-MeO-DiPT åï¼Œæ‰€æœ‰è¿·å¹»å‰‚çš„æ•ˆåº”éƒ½ä¼šé™ä½ã€‚

### å±é™©çš„ç›¸äº’ä½œç”¨

***è­¦å‘Šï¼š*** *è®¸å¤šç²¾ç¥æ´»æ€§ç‰©è´¨å•ç‹¬ä½¿ç”¨æ—¶ç›¸å¯¹å®‰å…¨ï¼Œä½†ä¸æŸäº›å…¶ä»–ç‰©è´¨ç»“åˆä½¿ç”¨æ—¶å¯èƒ½ä¼šå˜å¾—å±é™©ç”šè‡³å±åŠç”Ÿå‘½ã€‚ä»¥ä¸‹åˆ—è¡¨åˆ—å‡ºäº†ä¸€äº›å·²çŸ¥çš„å±é™©ç›¸äº’ä½œç”¨ï¼ˆå°½ç®¡ä¸ä¿è¯åŒ…å«æ‰€æœ‰ç›¸äº’ä½œç”¨ï¼‰ã€‚*

*åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶ï¼ˆä¾‹å¦‚ [Google](https://www.google.com)ã€[DuckDuckGo](https://www.duckduckgo.com)ã€[PubMed](https://pubmed.ncbi.nlm.nih.gov/)ï¼‰ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆå¯ä»¥å®‰å…¨é£Ÿç”¨ã€‚åˆ—å‡ºçš„ä¸€äº›ç›¸äº’ä½œç”¨æºè‡ª [TripSit](https://combo.tripsit.me)ã€‚*

*   **2C-T-X** - è¿™ä¸¤ç±»åŒ–åˆç‰©å•ç‹¬ä½¿ç”¨æ—¶éƒ½å¯èƒ½æ˜¯ä¸å¯é¢„æµ‹çš„ã€‚
*   **2C-X** - 5-MeO ç±»è¿·å¹»å‰‚å¯èƒ½ä¼šä»¥ä¸å¯é¢„æµ‹çš„æ–¹å¼å¢å¼ºå…¶ä»–è¿·å¹»å‰‚çš„æ•ˆåŠ›ã€‚
*   **[å¤§éº»](./å¤§éº».md)** - âš ï¸ å¯èƒ½å¢åŠ è´Ÿé¢å¿ƒç†æ•ˆåº”çš„é£é™©ï¼Œå¦‚[ç„¦è™‘](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)ã€[åæ‰§](/è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)å’Œ[ç²¾ç¥ç—…](/æ–‡æ¡£/å…´å¥‹å‰‚ç²¾ç¥ç—….md)ã€‚
*   **DOx** - 5-MeO ç±»è‰²èƒºç±»ç‰©è´¨åœ¨ç›¸äº’ä½œç”¨ä¸­å¯èƒ½ä¸å¯é¢„æµ‹ï¼Œç‰¹åˆ«æ˜¯å¢åŠ äº†ä¸æ„‰å¿«çš„èº«ä½“å‰¯ä½œç”¨çš„é£é™©ã€‚
*   **[MDMA](./MDMA.md)** - âš ï¸ ä¸€äº› 5-MeO è‰²èƒºç±»ç‰©è´¨æœ‰ç‚¹ä¸å¯é¢„æµ‹ï¼Œåº”å°å¿ƒä¸ MDMA æ··åˆã€‚
*   **[éº¦æ–¯å¡æ—](./éº¦æ–¯å¡æ—.md)** - 5-MeO ç±»è‰²èƒºç±»ç‰©è´¨åœ¨ç›¸äº’ä½œç”¨ä¸­å¯èƒ½ä¸å¯é¢„æµ‹ã€‚
*   **NBOMe** - ğŸ’” 5-MeO ç±»è‰²èƒºç±»ç‰©è´¨åœ¨ç›¸äº’ä½œç”¨ä¸­å¯èƒ½ä¸å¯é¢„æµ‹ï¼Œè€Œ NBOMe ç±»å·²çŸ¥å³ä½¿å•ç‹¬ä½¿ç”¨ä¹Ÿæ˜¯ä¸å¯é¢„æµ‹çš„ã€‚æœ€å¥½é¿å…è¿™ç§ç»„åˆã€‚
*   **[è‹¯ä¸™èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‹¯ä¸™èƒºç±»ç‰©è´¨.md)** - âš ï¸ å…´å¥‹å‰‚çš„ç„¦è™‘å’Œèšç„¦æ•ˆåº”å¢åŠ äº†ä¸æ„‰å¿«çš„æ€ç»´å¾ªç¯çš„æœºä¼šã€‚ç”±äºè¿·å¹»å‰‚æœ¬èº«å…·æœ‰åˆºæ¿€ä½œç”¨ï¼Œè¿™ç§ç»„åˆé€šå¸¸æ˜¯ä¸å¿…è¦çš„ã€‚
*   **å¯å¡å› ** - âš ï¸ å…´å¥‹å‰‚çš„ç„¦è™‘å’Œèšç„¦æ•ˆåº”å¢åŠ äº†ä¸æ„‰å¿«çš„æ€ç»´å¾ªç¯çš„æœºä¼šã€‚ç”±äºè¿·å¹»å‰‚æœ¬èº«å…·æœ‰åˆºæ¿€ä½œç”¨ï¼Œè¿™ç§ç»„åˆé€šå¸¸æ˜¯ä¸å¿…è¦çš„ã€‚
*   **[å³ç¾æ²™èŠ¬](./å³ç¾æ²™èŠ¬.md)** - å…³äºè¿™ç§ç»„åˆçš„ä¿¡æ¯å¾ˆå°‘ã€‚
*   **æ›²é©¬å¤š** - â›” å¢åŠ [è¡€æ¸…ç´ ç»¼åˆå¾](/æ–‡æ¡£/è¡€æ¸…ç´ ç»¼åˆå¾.md)çš„é£é™©ã€‚
*   **aMT** - â›” å¢åŠ [è¡€æ¸…ç´ ç»¼åˆå¾](/æ–‡æ¡£/è¡€æ¸…ç´ ç»¼åˆå¾.md)çš„é£é™©ã€‚
*   **[å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](/æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md)** - â›” å¢åŠ [è¡€æ¸…ç´ ç»¼åˆå¾](/æ–‡æ¡£/è¡€æ¸…ç´ ç»¼åˆå¾.md)çš„é£é™©ã€‚
*   **[PCP](./PCP.md)** - å…³äºè¿™ç§ç»„åˆçš„ä¿¡æ¯å¾ˆå°‘ã€‚å¯èƒ½å¢åŠ ç²¾ç¥ç—…å’Œè¿‡åº¦åˆºæ¿€çš„é£é™©ã€‚

5-MeO-DiPT æ˜¯ä¸€ç§å•èƒºå†æ‘„å–æŠ‘åˆ¶å‰‚ (MRI)ã€‚[\[8\]](#cite_note-8)[\[9\]](#cite_note-9) 5-MeO-DiPT å’Œ [å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](/æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md) æ˜¯ä¸€ç§æ½œåœ¨çš„å±é™©ç»„åˆã€‚MAOI å¾ˆå¯èƒ½ä¼šä¸å¯é¢„æµ‹åœ°å¢åŠ  5-MeO-DiPT çš„æ•ˆåº”ã€‚å¼ºçƒˆä¸å»ºè®®åœ¨æœç”¨å¤„æ–¹ MAOI æ—¶æœç”¨æ­¤åŒ–å­¦å“ã€‚

## æ³•å¾‹åœ°ä½

*   **å·´è¥¿**ï¼šæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”®æ˜¯éæ³•çš„ï¼Œå› ä¸ºå®ƒè¢«åˆ—åœ¨ Portaria SVS/MS nÂº 344 ä¸­ã€‚[\[10\]](#cite_note-10)
*   **ä¸­å›½**ï¼š5-MeO-DiPT åœ¨ä¸­å›½æ˜¯éæ³•çš„ã€‚[\[11\]](#cite_note-11)
*   **ä¸¹éº¦**ï¼š5-MeO-DiPT åœ¨ä¸¹éº¦æ˜¯éæ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **å¾·å›½**ï¼šè‡ª 2000 å¹´ 10 æœˆ 10 æ—¥èµ·ï¼Œ5-MeO-DiPT å— Anlage I BtMGï¼ˆ*éº»é†‰å“æ³•ï¼Œé™„è¡¨ I*ï¼‰ç®¡åˆ¶[\[12\]](#cite_note-12)[\[13\]](#cite_note-13)ã€‚æœªç»è®¸å¯ï¼Œåˆ¶é€ ã€æ‹¥æœ‰ã€è¿›å£ã€å‡ºå£ã€è´­ä¹°ã€å‡ºå”®ã€é‡‡è´­æˆ–åˆ†å‘å®ƒæ˜¯éæ³•çš„ã€‚[\[14\]](#cite_note-14)
*   **å¸Œè…Š**ï¼š5-MeO-DiPT åœ¨å¸Œè…Šæ˜¯éæ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **æ—¥æœ¬**ï¼š5-MeO-DiPT åœ¨æ—¥æœ¬æ˜¯éæ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **æ‹‰è„±ç»´äºš**ï¼š5-MeO-DiPT åœ¨æ‹‰è„±ç»´äºšæ˜¯éæ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **æ–°è¥¿å…°**ï¼š5-MeO-DiPT å¯è¢«è§†ä¸º DMT çš„ç±»ä¼¼ç‰©ï¼Œè¿™ä½¿å…¶åœ¨æ–°è¥¿å…°æˆä¸º C ç±»å—æ§è¯ç‰©ã€‚[\[15\]](#cite_note-15)
*   **æ–°åŠ å¡**ï¼š5-MeO-DiPT åœ¨æ–°åŠ å¡æ˜¯éæ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](/æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)*\]
*   **ç‘å…¸**ï¼š5-MeO-DiPT åœ¨ç‘å…¸æ˜¯éæ³•çš„ã€‚[\[16\]](#cite_note-16)
*   **ç‘å£«**ï¼š5-MeO-DiPT æ˜¯ Verzeichnis E ä¸­æ˜ç¡®åˆ—å‡ºçš„å—æ§ç‰©è´¨ã€‚[\[17\]](#cite_note-17)
*   **è‹±å›½**ï¼š5-MeO-DiPT åœ¨è‹±å›½æ˜¯ A ç±»è¯ç‰©ï¼Œå› ä¸ºå®ƒæ˜¯è¯ç‰© 5-HO-DiPT çš„é†šï¼Œç”±äºè‰²èƒºåŒ…ç½—æ¡æ¬¾ï¼Œåè€…æ˜¯ A ç±»è¯ç‰©ã€‚[\[18\]](#cite_note-18)
*   **ç¾å›½**ï¼š5-MeO-DiPT æ˜¯é™„è¡¨ 1 å—æ§ç‰©è´¨ã€‚2003 å¹´ 4 æœˆ 4 æ—¥ï¼Œç¾å›½ç¼‰æ¯’å±€ï¼ˆDEAï¼‰æ ¹æ®â€œç´§æ€¥åˆ—ç®¡â€ç¨‹åºå°† 5-MeO-DiPT å’Œ Î±MT åˆ—å…¥å—æ§ç‰©è´¨æ³•æ¡ˆé™„è¡¨ Iã€‚è¿™äº›è¯ç‰©äº 2004 å¹´ 9 æœˆ 29 æ—¥æ­£å¼åˆ—å…¥é™„è¡¨ Iã€‚[\[19\]](#cite_note-19)

## å¦è§

*   [è´Ÿè´£ä»»çš„ç”¨è¯](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)
*   [ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)
*   [è‰²èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)
*   [5-MeO-MiPT](./5-MeO-MiPT.md)
*   [4-AcO-DiPT](./4-AcO-DiPT.md)
*   [DiPT](./DiPT.md)

## å¤–éƒ¨é“¾æ¥

*   [5-MeO-DiPT (Wikipedia)](https://en.wikipedia.org/wiki/5-Methoxy-diisopropyltryptamine)
*   [5-MeO-DiPT (Erowid Vault)](https://erowid.org/chemicals/5meo_dipt/5meo_dipt.shtml)
*   [5-MeO-DiPT (TiHKAL / Isomer Design)](http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=37)

### è®¨è®º

*   [The Big & Dandy 5-MeO-DiPT Thread (Bluelight)](https://www.bluelight.org/xf/threads/57817)

## å‚è€ƒèµ„æ–™

1.  [â†‘](#cite_ref-1) [Alexander Shulgin] (1976). [*Pharmacology Notes I (The Shulgin Lab Books)*](https://erowid.org/library/books_online/shulgin_labbooks/shulgin_labbook1_searchable.pdf) (PDF). Lafayette, CA: Erowid. p. 176.
2.  [â†‘](#cite_ref-2) [Shulgin, A. T.]; Carter, M. F. (1980). "N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity". *Communications in psychopharmacology*. **4** (5): 363â€“369. [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0145-5699](//www.worldcat.org/issn/0145-5699). [OCLC](http://en.wikipedia.org/wiki/OCLC) [3012956](//www.worldcat.org/oclc/3012956). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [6949674](//www.ncbi.nlm.nih.gov/pubmed/6949674).
3.  [â†‘](#cite_ref-Shulgin1997_3-0) [Shulgin, Alexander]; Shulgin, Ann (1997). *[TiHKAL: The Continuation]* United States: Transform Press. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [0-9630096-9-9](http://en.wikipedia.org/wiki/Special:BookSources/0-9630096-9-9). [OCLC](http://en.wikipedia.org/wiki/OCLC) [38503252](//www.worldcat.org/oclc/38503252).
4.  [â†‘](#cite_ref-pmid17223101_4-0) Nagai, F.; Nonaka, R.; Satoh, K.; Kamimura, H. (2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain". *European Journal of Pharmacology*. **559** (2â€“3): 132â€“137. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.ejphar.2006.11.075](//doi.org/10.1016%2Fj.ejphar.2006.11.075). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1879-0712](//www.worldcat.org/issn/1879-0712). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0014-2999](//www.worldcat.org/issn/0014-2999). [OCLC](http://en.wikipedia.org/wiki/OCLC) [01568459](//www.worldcat.org/oclc/01568459). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [17223101](//www.ncbi.nlm.nih.gov/pubmed/17223101).
5.  [â†‘](#cite_ref-5) Ray, T. S. (2 February 2010). Manzoni, O. J., ed. ["Psychedelics and the Human Receptorome"](https://dx.plos.org/10.1371/journal.pone.0009019). *PLoS ONE*. **5** (2): e9019. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1371/journal.pone.0009019](//doi.org/10.1371%2Fjournal.pone.0009019). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1932-6203](//www.worldcat.org/issn/1932-6203).
6.  â†‘ [6.0](#cite_ref-Noworyta-Sokolowska2016_6-0) [6.1](#cite_ref-Noworyta-Sokolowska2016_6-1) Noworyta-SokoÅ‚owska, K.; KamiÅ„ska, K.; Kreiner, G.; RogÃ³Å¼, Z.; GoÅ‚embiowska, K. (2016). ["Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5047954). *Neurotoxicity Research*. **30** (4): 606â€“619. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/s12640-016-9654-0](//doi.org/10.1007%2Fs12640-016-9654-0). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1476-3524](//www.worldcat.org/issn/1476-3524). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1029-8428](//www.worldcat.org/issn/1029-8428). [OCLC](http://en.wikipedia.org/wiki/OCLC) [50166444](//www.worldcat.org/oclc/50166444). [PMC](http://en.wikipedia.org/wiki/PubMed_Central) [5047954](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5047954). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [27461536](//www.ncbi.nlm.nih.gov/pubmed/27461536).
7.  [â†‘](#cite_ref-7) Randall C. Baselt (2008). *Disposition of Toxic Drugs and Chemicals in Man* (8th ed.). Foster City, CA: Biomedical Publications. pp. 975â€“976. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [978-0-9626523-7-0](http://en.wikipedia.org/wiki/Special:BookSources/978-0-9626523-7-0). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0009-9147](//www.worldcat.org/issn/0009-9147).
8.  [â†‘](#cite_ref-8) Tayebati, S. K.; Tomassoni, D.; Nwankwo, I. E.; Di Stefano, A.; Sozio, P.; Cerasa, L. S.; Amenta, F. (2013). "Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain". *Drug Targets - CNS & Neurological Disorders*. **12** (1): 94â€“103. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.2174/1871527311312010015](//doi.org/10.2174%2F1871527311312010015). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1568-007X](//www.worldcat.org/issn/1568-007X). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [23244432](//www.ncbi.nlm.nih.gov/pubmed/23244432).
9.  [â†‘](#cite_ref-9) Trabucchi, M.; Govoni, S.; Battaini, F. (1986). "Changes in the interaction between CNS cholinergic and dopaminergic neurons induced by L-alpha-glycerylphosphorylcholine, a cholinomimetic drug". *Il Farmaco, Edizione Scientifica*. **41** (4): 325â€“334. [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0430-0920](//www.worldcat.org/issn/0430-0920). [OCLC](http://en.wikipedia.org/wiki/OCLC) [1064491979](//www.worldcat.org/oclc/1064491979). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [3709792](//www.ncbi.nlm.nih.gov/pubmed/3709792).
10. [â†‘](#cite_ref-10) ["RESOLUÃ‡ÃƒO DA DIRETORIA COLEGIADA - RDC NÂ° 130, DE 2 DE DEZEMBRO DE 2016"](http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7) (in Portuguese). AgÃªncia Nacional de VigilÃ¢ncia SanitÃ¡ria (Anvisa) [National Sanitary Surveillance Agency]. December 5, 2016. Retrieved January 8, 2020.
11. [â†‘](#cite_ref-11) ["å…³äºå°å‘ã€Šéè¯ç”¨ç±»éº»é†‰è¯å“å’Œç²¾ç¥è¯å“åˆ—ç®¡åŠæ³•ã€‹çš„é€šçŸ¥"](https://web.archive.org/web/20170906191704/http://www.sfda.gov.cn/WS01/CL0056/130753.html) (in Chinese). å›½å®¶é£Ÿå“è¯å“ç›‘ç£ç®¡ç†æ€»å±€ [China Food and Drug Administration (CFDA)]. September 27, 2015. Archived from [the original](http://www.sfda.gov.cn/WS01/CL0056/130753.html) on September 6, 2017. Retrieved August 19, 2020.
12. [â†‘](#cite_ref-12) ["Gesetz Ã¼ber den Verkehr mit BetÃ¤ubungsmitteln: Anlage I"](https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html) (in German). Bundesamt fÃ¼r Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
13. [â†‘](#cite_ref-13) ["Vierzehnte Verordnung zur Ã„nderung betÃ¤ubungsmittelrechtlicher Vorschriften"](https://www.bgbl.de/xaver/bgbl/start.xav?start=%2F%2F*%5B%40attr_id%3D%27bgbl100s1414b.pdf%27%5D#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl100s1414b.pdf%27%5D__1576702069328). *Bundesgesetzblatt Jahrgang 2000 Teil I Nr. 44* (in German). Bundesanzeiger Verlag (published September 30, 2000). September 27, 2000. pp. 1414â€“1415. [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0341-1095](//www.worldcat.org/issn/0341-1095). Retrieved December 18, 2019.
14. [â†‘](#cite_ref-14) ["Gesetz Ã¼ber den Verkehr mit BetÃ¤ubungsmitteln: Â§ 29"](https://www.gesetze-im-internet.de/btmg_1981/__29.html) (in German). Bundesamt fÃ¼r Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
15. [â†‘](#cite_ref-15) ["Schedule 1: Class A controlled drugs"](http://www.legislation.govt.nz/act/public/1975/0116/latest/whole.html#DLM436576). *Misuse of Drugs Act 1975*. Parliamentary Counsel Office (PCO). Retrieved September 19, 2020.
16. [â†‘](#cite_ref-16) ["Svensk fÃ¶rfattningssamling FÃ¶rordning om Ã¤ndring i fÃ¶rordningen (1999:58) om fÃ¶rbud mot vissa hÃ¤lsofarliga varor"](http://www.notisum.se/rnp/sls/sfs/20040696.pdf) (PDF) (in Swedish) (published September 7, 2004). August 19, 2004. SFS 2004:696.
17. [â†‘](#cite_ref-17) ["Verordnung des EDI Ã¼ber die Verzeichnisse der BetÃ¤ubungsmittel, psychotropen Stoffe, VorlÃ¤uferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html) (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.
18. [â†‘](#cite_ref-18) ["Schedule 2: Part I: Class A Drugs"](http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I). *"Misuse of Drugs Act 1971"*. UK Government. Retrieved August 20, 2020.
19. [â†‘](#cite_ref-19) [*Schedules of Controlled Substances: Placement of Alpha- Methyltryptamine and 5-Methoxy-N,N-Diisopropyltryptamine Into Schedule I*](https://www.deadiversion.usdoj.gov/fed_regs/rules/2004/fr0929.htm)